((This story was generated using AI and automation, please see
disclaimer https://bit.ly/rtrsnai))
Overview
* US fertility clinic operator's Q2 revenue rose 17% yr/yr, driven by acquisitions and organic growth
* Net income turned positive, aided by a gain on Birmingham clinic remeasurement
* Adjusted EBITDA remained negative at -$1.0 mln, reflecting ongoing platform investments
Outlook
* Company plans to drive organic growth across its existing clinic network
* INVO Fertility continues to evaluate acquisition opportunities for established, profitable fertility clinics
* Company investing in operations, HR, and finance to support expansion and improve scalability
Result Drivers
* FAMILY BEGINNINGS ACQUISITION - Q2 revenue growth was primarily attributed to the addition of Family Beginnings following its February 2026 acquisition
* ORGANIC CLINIC GROWTH - Continued growth initiatives at Wisconsin Fertility Institute and the Georgia clinic contributed to first-half revenue
* BIRMINGHAM CLINIC OWNERSHIP - Gain on remeasurement and future economics resulted from acquiring full ownership of the Birmingham clinic
Company press release: ID:nGNX37HlZY
Key Details
Metric Beat/Mis Actual Consensu
s s
Estimate
Q2 $2.18
Revenue mln
Q2 Net $888,740
Income
Q2 -$1.03
Adjusted mln
EBITDA
Reuters Recommended Reads
* Aug 14 - Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive
* Aug 14 - Healthy Extracts Q2 net revenue rises 113% on acquisitions
* Aug 14 - Medical device maker Retractable Technologies' Q2 sales drop on weak EasyPoint needle orders
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact .
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)